Novel drug-induced respiratory emergencies

P. Camus (Dijon, France)

Source: Annual Congress 2006 - Drug-induced lung injury – new aspects

Session: Drug-induced lung injury – new aspects
Session type: Symposium
Number: 3503

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Camus (Dijon, France). Novel drug-induced respiratory emergencies. Annual Congress 2006 - Drug-induced lung injury – new aspects

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia Source: Eur Respir J 2013; 41: 402-409 Year: 2013
Infection and comorbidity Source: Eur Respir Mon 2013; 59: 64-79 Year: 2013
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002
Fatal and near-fatal asthma Source: Eur Respir Mon 2011; 51: 130-146 Year: 2011
Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003
Fatal asthma in Sweden Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Fungal VAP Source: Eur Respir Mon 2011; 53: 122-137 Year: 2011
Hypersensitivity pneumonitis Source: Respipedia Article Year: 2018
Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005
Complex chronic comorbidities of COPD Source: Eur Respir J 2008; 31: 204-212 Year: 2008
The management of acute life-threatening asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=396 Year: 2003
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis Source: Eur Respir J 2003; 22: 809-814 Year: 2003
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Benralizumab for severe asthma associated with extra-airway eosinophilic diseases Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality Source: Eur Respir J 2010; 35: 1303-1311 Year: 2010